|View printer-friendly version|
|INC Research to Discuss Clinical Trial Management for Latin America|
With a Focus on Reducing Clinical Trial Risk, Nicolas Sandoval Will Present How a CRO Partner Addresses Challenges at CBI’s Clinical Trials in Latin America 2010
Raleigh, NC, Sept. 7, 2010 – INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, will feature Nicolas Sandoval, SCRA/CTL/LRA, clinical team leader and local regulatory adviser, Clinical Operations, at the CBI Clinical Trials in Latin America 2010 conference on Sept. 9–10 in Lima, Peru.
Sandoval will discuss the advantages of bringing regional experts to the table to assist with project planning, metrics evaluation and execution of clinical trials in his presentation “Reducing Clinical Trial Risk in Latin America — How Partnering with a CRO Helps to Address the Challenges” on Sept. 9 at 3:00 p.m. He will walk through the importance of partnering with a company thatcan support repeatable processes and identify and plan for risks to improve the probability of success.
Latin America is an increasingly desirable location for running clinical trials, and this conference is focused on the collaboration with colleagues and industry counterparts that is necessary to address the challenges of developing, executing and completing clinical trials in Latin America.
INC Research offers full-spectrum clinical trials services in regional locations from five established offices, including Argentina, Mexico, Brazil, Peru and Chile. For more information on the global CRO’s trusted experience in Latin America, click here and its process-driven clinical research methodology, The Trusted Process, click here.
About INC Research® Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.